ARCA biopharma, Inc. (now Oruka Therapeutics, Inc.)

ARCA biopharma, Inc. was a clinical-stage biotechnology company applying a precision-medicine approach to genetically targeted therapies for cardiovascular diseases (lead candidate Gencaro / bucindolol).